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Abstract.  The treatment of embryonic chick chondro- 
cyte cultures with heparin  results in a decrease in col- 
lagen synthesis. One of the collagens synthesized by 
hypertrophic chondrocytes, specifically type X colla- 
gen, may play an important role in cartilage mineral- 
ization and endochondral ossification. Recently a new 
short chain collagenous component was found in cul- 
tures of rat vascular smooth muscle cells (Majack, 
R. A., and P. Bornstein,  1985, J.  Cell Biol.,  100: 
613-619).  The present study was initiated to investigate 
heparin's effect on type X  collagen in embryonic chick 
chondrocytes and to further evaluate the nature of the 
short chain component synthesized by rat vascular 
smooth muscle cells. 
Different tissues may respond differently to the ad- 
ministration  of heparin.  In chondrocyte cultures hepa- 
fin decreased both total collagen synthesis as well as 
the synthesis of type X collagen.  There was an ac- 
cumulation of collagen precursors, found principally in 
the cell layer compartment,  which appeared to be the 
result of heparin's inhibition of the NH2-terminal pro- 
tease.  In cultures of rat vascular smooth muscle cells 
heparin  was found to increase the synthesis of a  short 
chain collagenous component as previously reported. 
However, comparison with a type X  collagen standard 
showed this to be different from type X. 
In all cases, the effect of heparin on collagen chain 
precursors, chondrocyte type X  synthesis, and synthe- 
sis of a vascular smooth muscle short chain collagen 
was shown to be reversible.  Similar effects were ob- 
tained by adding chondroitin  sulfate to chondrocytes, 
suggesting a role for extracellular matrix components 
in the modulation of collagen synthesis.  These findings 
are consistent with the concept of a group of short 
chain collagens with type X  collagen being unique to 
hypertrophic chondrocytes. 
H 
EPARIN,  a  large,  negatively  charged  glycosamino- 
glycan,  is  a  commonly used anticoagulant  in  the 
prevention  and treatment  of venous thrombosis.  It 
inhibits the clotting of blood and the formation of fibrin clots. 
Venous thrombosis is a life-threatening  disease, often afflict- 
ing patients that require long-term hospital bed rest and im- 
mobilization.  A large percentage of these patients are victims 
of trauma with multiple fractures who have undergone major 
surgery and require considerable periods of convalescence. 
In both groups, it is important that the molecular and cellular 
events associated with the healing process proceed normally. 
Of particular  importance is the synthesis,  processing,  and 
distribution of the various collagen types, the major proteins 
of the repairative  process in soft tissue and bone. The focus 
of this study is the effect of heparin on collagen  synthesis, 
processing, and distribution  by chick permanent and calcify- 
ing sternal  chondrocytes,  rat vascular smooth muscle cells, 
and rat Swarm tumor cells treated in culture. 
Of particular interest  is heparin's  effect on the synthesis 
and distribution of type X collagen.  This short chain colla- 
gen with a molecular weight of 59K is unique to hypertrophic 
chondrocytes (24)  in the zone of degeneration  and  provi- 
sional calcification  in growth cartilage  (5, 26) and in the os- 
sifying cartilage of fracture callus (6). It is therefore a colla- 
gen that is present at sites of endochondral  bone formation 
during the processes of both growth and repair.  Embryonic 
chick sterna are comprised of two types of chondrocytes,  cal- 
cifying and "permanent" chondrocytes,  which vary in regard 
to phenotypic expression  of type X collagen  (4).  Although 
the entire  sternum  will eventually  calcify during  develop- 
ment and maturation  of the chicken,  only the cells found in 
the proximal  sternum,  which is the region that will start to 
calcify first, are capable of synthesizing  and secreting  type 
X collagen  beginning  on day 9 of embryonic development 
(3, 21). 
At least some of the procollagen molecules manufactured 
by chondrocytes are processed by way of the Golgi apparatus 
and then released by exocytosis (2, 20). Unlike most other 
collagen types, type X collagen is believed to be secreted by 
chondrocytes without undergoing significant proteolytic cleav- 
age at the NH2- and COOH-terminal domains.  Treatment of 
chick chondrocytes in culture with exogenous proteoglycan 
results in a decrease in the synthesis and release of both col- 
lagen and proteoglycan (7). A similar decrease is seen when 
rat granulation  tissue cells are treated  with various glycos- 
aminoglycans  (9).  A more recent study has suggested  that 
heparin  and related  glycosaminoglycans  may play a role in 
the modulation  of the secretory phenotype of rat vascular 
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mol-wt collagenous protein (13, 14). 
We have studied the effect of heparin on collagen synthesis 
by several types of normal rat and chick cells and have in- 
cluded  cells  from  a  benign  neoplasm,  the  Swarm  chon- 
drosarcoma.  Our  results  suggest  that  these  cells  respond 
differently to the action of heparin with respect to collagen 
synthesis  and  its  modulation.  Heparin  has  an  inhibitory 
effect on the synthesis of type X collagen, an observation that 
may be of clinical importance given that synthesis of this col- 
lagen is unique to the process of endochondral ossification. 
Materials and Methods 
Cell Cultures 
Sterna from 17-d-old White Leghorn chick embryos were dissected from 
their surrounding perichondrium using a dissecting microscope. Each ster- 
num was divided into two areas: the distal (caudal) portion comprised of 
permanent, noncalcifying cells and the proximal (cephalic) portion com- 
prised of the cells of presumptive calcification. The tissue was placed into 
separate 60-mm tissue culture dishes, each containing 10 ml of sterile DME 
and 25  mM  Hepes (DME-Hepes) supplemented with ascorbic acid (50 
~tg/ml), penicillin (10,000 U/ml), and streptomycin (10,000 ~tg/mi). The tis- 
sue was morselized, rinsed twice with medium, and digested in 3 ml 0.05 % 
hyaluronidase (GIBCO,  Grand Island, NY) in saline G at 37°C in a shaking 
water bath for 15 rain. The solution was removed, the tissue was rinsed and 
treated with a mixture of 0.5% trypsin (GIBCO) and 4,000 U of bacterial 
collagenase (CLSPA, CooperBiomedical, Inc., Malvern, PA) at 37°C for 
1.5 h. The supernatant containing the released cells was separated from re- 
sidual tissue by filtration through a nitex screen and the cells were then cen- 
trifuged at 300 g for 10 rain. The supernatant was removed, the cell pellet 
resuspended and washed twice with media, and the cells were plated at a 
density of 5  ×  104  cells per cm  2.  Cells were incubated in  DME  sup- 
plemented with 25 mM Hepes, 10% FBS, ascorbic acid (50 p,g/ml), penicil- 
lin (10,000 U/ml), and streptomycin  (10,000 ~tg/ml), and grown to confluence 
in a humidified incubator with a 5%  CO2 atmosphere at 370C. 
Swarm  chondrosarcoma  (27)  tumors  were  perpetuated  in  Sprague- 
Dawley rats and were collected at 4 wk. Cells were prepared and plated as 
described for the chick sternal chondrocytes. Rat vascular smooth muscle 
cells were isolated as previously described by enzymatic release from 6-wk- 
old rat aortae and grown to confluence (18). Subsequent procedures and 
treatments were similar as for other cells. 
Glycosaminoglycan Treatment 
Cells of each type were treated with heparin or chondroitin sulfate (both 
from Sigma Chemical Co., St. Louis, MO) solubilized in saline G at con- 
centrations of either 50 or 100 p.g/ml for up to 48 h before metabolic label- 
ing. Cell cultures used to demonstrate reversibility were treated for 48 h and 
then rinsed twice with the culture media and grown for an additional 48 h 
without proteoglycan before metabolic labeling with isotope. 
Metabolic Labeling and Harvesting of  Cells 
Before radiolabeling media was removed and cells were preincubated for 1 h 
in a solution of DME containing 25 mM Hepes, 10% FBS, 50 I.tg/ml ascor- 
bic acid,  50  I~g/ml 13-aminopropionitrile,  penicillin (10,000  U/ml),  and 
streptomycin (10,000 l~g/ml).  After preincubation the media was removed 
and replaced with 5 ml media containing 5  IxCi/ml [~C]proline (U-[14C]  - 
proline; New England Nuclear, Boston, MA). The media were removed af- 
ter 10 h and placed in protease inhibitors (1 mM phenylmethylsulfonyl fluo- 
ride (PMSF),  10 mM N-ethylmaleimide, and 25 mM EDTA)  at 4°C. The 
remaining cell layer was rinsed with 1 ml Tris-huffered saline (0.15 M NaCl, 
0.05 M Tris, pH 7.5). The rinse was pooled with the collected media and cen- 
trifuged at 300 g  for  10 min.  The cell layers were lifted using a  rubber 
scraper and placed into 2 ml of the protease inhibitor solution described 
above. The culture dishes were washed with an additional 2  ml, and this 
was  added  to  the  harvested  cells.  Using  a  sonicator  (Heat  Systems- 
Ultrasonics, Inc., Farmingdale, NY) at 20,000 Hz, cells were disrupted and 
then centrifuged at 10,000 g for 1 h at 4°C. The supernatants from both me- 
dia and cell layers were stored at  -20°C. 
Preparation of Dype  X Collagen Standard 
Type X collagen standards from rat and chicken were prepared by organ cul- 
ture of distal growth plate dissected from the costochondral junction and 
preincubated in culture media for  1 h  before a  10-h radiolabeling with 
5  ~tCi/ml  [~4C]proline  (U-[t4C]proline;  New  England  Nuclear).  After 
labeling the tissue was homogenized in extracting buffer (1.0 M NaCI, 0.05 
M  "Iris, pH 7.5) supplemented with protease inhibitors using a Tissunizer 
(Tekmar Co., Cincinnati, OH) at 4°C, stirred for 1 h, and centrifuged at 
30,000 g for 30 rain. Supernatants were dialyzed against Tris-buffered saline 
with 0.2 mM PSMF at 4°C, and the proteins were precipitated by the addi- 
tion of ammonium sulfate (33 % final saturation). 
Protein Precipitation and SDS-PAGE 
Proteins in media and cell layers were precipita~:l with 10%  TCA in the 
presence of  0.5 ~tg/ml pepstatin (Worthington Biochemical Corp., Freehold, 
NJ) for 30 rain at 4°C, and centrifuged at 500 g for 2 rain at 4°C. The pellets 
Figure 1.  Effect  of heparin  on  chick 
chondrocytes  prepared  from either  the 
(a) calcifying or (b) permanent region of 
embryonic  sternae.  After 48 h with or 
without heparin treatment, confluent cell 
cultures were labeled with p4C]proline. 
Specimens were reduced with DTT and 
analyzed  by  7.5%  SDS-PAGE.  An  in- 
crease can be seen in the ctl  precursor 
bands (pN) in both the cell layer (cl) and 
media  (m)  compartments  of  heparin- 
treated cultures (lanes 2, 4, 6, and 8). A 
concomitant  diminution  occurs  in  the 
area of the ctl band as well as a decrease 
in the type X  band after treatment with 
heparin (lanes 1  and 2). 
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95% ethyl alcohol at 4°C, and analyzed by SDS-PAGE using a 7.5% acryl- 
amide gel (11). High and low molecular weight globular protein standards 
(Pharmacia Fine Chemicals, Piscataway, NJ) were used to estimate molecu- 
lar weights of unknowns. Selected samples were treated with 100 mM di- 
thiothreitol (DTI';  Bio-Rad Laboratories,  Richmond, CA) to  reduce di- 
sulfide bonds. Gels were processed for fluorography according to Bonner 
and Laskey (1) using EN3HANCE (New England Nuclear) and exposed on 
presensitized X-OMAT AR Kodak film (12). Quantitative evaluation of col- 
lagen types synthesized by ceils was performed by scanning of the fluoro- 
grams with a densitometer (E-C Apparatus Corporation, St.  Petersburg, 
FL) connected to an integrator (SP-4270;  Spectraphysics, Inc., Mountain- 
view, CA). 
Enzyme Digestions 
For limited proteolysis samples from the media and cell layers were dialyzed 
in 0.5 M acetic acid, pH 2.6 and pepsin A (hog stomach; Worthington Bio- 
chemical Corp.) was added to a final concentration of 1 mg/ml and digestion 
proceeded for 24 h in a dialysis bag at 4°C. The reaction was stopped by 
dialysis against 10 mM ammonium bicarbonate pH 8.0 for 12 h followed by 
lyophilization. Collagen quantitation using bacterial collagenase was per- 
formed in triplicate using a modification of the method described by Peter- 
kofsky and Diegelman (19). Highly purified bacterial collagenase (Form III; 
Advance Biofactures, Lynbrook, NY) was added to 40,000 dpm of sample 
in the presence of 10 mM NEM and 0.2 mM PMSF and incubated at 37°C 
for 4 h. Collagenase-digested samples were cooled to 4°C and proteins were 
precipitated with 10% TCA and 0.5% tannic acid, and counts released into 
the supernatant were measured in 10 ml Aqnasol (New England Nuclear) 
using a scintillation counter (model LS6800; Beckman Instruments, Inc., 
Palo Alto, CA). 
Quantitation of  D NA 
DNA was measured in cell layers using a bisbenzimidazole fluorometric 
method (10). 
Results 
Heparin-induced Changes in Chick 
Chondrocyte Cell Cultures 
When cells from the distal region of the chick sternae (per- 
manent or noncalcifying chondrocytes) were treated for 48 h 
with  100 lxg/ml of heparin before metabolic labeling with 
[14C]proline,  several  reproducible  and  reversible changes 
were observed. Changes took place in the pattern of proteins 
Table L Effect of  Heparin on Total Protein, 
Type X Collagen, and Total Collagen Synthesis 
Collagenase  Type X synthesis 
sensitive  (density of 
(dpm)*  fluorogram)* 
Cell  Cell 
Total  incorporation  layer  Media  layer  Media 
(dpm  x  lO-3/ng DNA)  %  %  %  % 
Control  2.2  16.4  21.5  16.4  11.8 
Heparin  1.8  16.5  15.4  6.3  5.5 
Cultures  of calcifying  chondrocytes were  incubated  with  [14C]proline and 
both media and cell layers were assayed for collagen using bacterial  col- 
lagenase.  Total  incorporation  of isotope into media plus cell layer fractions 
were normalized to DNA content. There is a significant decrease in collagen 
synthesis measured in the media compartment of heparin-treated  cultures.  Also 
note the decrease in type X synthesis in both cell layer and media compartments 
as a result of heparin treatment. 
* Collagenase assays were performed in triplicate in two separate experiments 
and all values  were within 8 % of the mean. 
Results from gel lanes of pepsinized and nonpepsinized material showed the 
same inhibition  of type X synthesis (for example, see Fig. 2). 
seen by SDS-PAGE in both the media and cell layer com- 
partments.  All of the effects occurred in a dose-dependent 
fashion with a  maximum effect seen at a  concentration of 
100 pg/mi. 
In Fig.  1 a quantitative difference can be seen in a band 
migrating more slowly than the al type II collagen chain in 
both compartments (lanes  6 and 8).  This band,  probably 
representing the pN al chain of type II collagen is relatively 
increased as a result of heparin treatment compared with the 
control lane. A concomitant diminution in the region of the 
al band can be seen in both compartments as compared with 
controls (Fig.  1, lanes 5-8). The fact that the density of al 
precursors does not change after reduction of disulfide bonds 
suggests that cleavage of the disulfide bonded COOH pro- 
peptides has proceeded normally and that the molecule that 
is accumulating is comprised of pN Q1  chains. 
Similar effects of heparin can be seen in the two compart- 
ments of the calcifying chondrocyte cultures (Fig.  1, lanes 
1-4).  The same increase in the region of type H precursor 
chains can be seen in both the media and cell layer compart- 
ments (Fig. 1, lanes 2 and 4). There is also a relative diminu- 
tion in al in both compartments. In addition type X collagen, 
which is typically synthesized only by the calcifying chon- 
drocytes, is relatively decreased in cell cultures treated with 
heparin (Fig. 1, lanes I and 2). No type X collagen synthesis 
was seen in any of the cell cultures prepared from the caudal 
areas of sternae. 
Quantitative assays for collagen of both media and cell 
layer compartments using bacterial collagenase revealed a 
27 % decrease in collagenase-sensitive material in the media 
compartment of heparin-treated cultures with no significant 
change noted in the cell layer compartment (Table I). Total 
incorporation of isotope into media plus cell layer fractions 
were normalized to DNA content and showed a small decrease 
in total protein synthesis as a  result of heparin treatment. 
Densitometric scanning of fluorograms of both media and 
cell layers showed an overall decrease of 58 % in type X col- 
lagen in both compartments after heparin treatment (Table I). 
Fig. 2 shows the results of  treatment of  cell layers with pep- 
sin. The component that accumulated in the region of pN al 
disappeared after pepsin digestion. At the same time an in- 
crease can be seen in the ctl band (Fig. 2, lanes 2 and 4). 
These results indicate that the pN al  precursor chains are 
cleaved with pepsin and the products now comigrate with al. 
As expected, limited proteolysis of type X collagen chains 
with pepsin produces components migrating faster on gels, 
reflecting the removal of the globular NH2 and COOH do- 
mains of type X  (17, 25). 
Heparin Augments Synthesis of  a Short Chain 
Collagenoas  Component in Rat Vascular Smooth 
Muscle Cells (SC,~,) I 
When confluent cell cultures of rat vascular smooth muscle 
cells were treated with 100 gg/ml heparin, a similar accumu- 
lation  in  type I  collagen  precursors  was  seen,  but  these 
precursors were predominantly found in the media (Fig. 3, 
lane 4). Also a marked decrease in the region of ¢tl and a2 
components can be seen in the cell layer compartment of 
heparin-treated cultures (Fig. 3, lanes 1 and 2). 
1. Abbreviation used in this paper: SC,~m, short chain collagenous compo- 
nent in rat vascular smooth muscle cell. 
Brown and Balian Heparin Effect  on Short Chain Collagens  1009 Figure 2.  Pepsin digestion of radiolabeled material isolated from 
the cell layer compartment of calcifying sternal chick chondrocyte 
cultures. Note the relative increase of the ctl precursor (p~ indi- 
calexl by small arrowheads)  after heparin treatment (compare lanes 
1 and 3). This increase in the pN region disappears with pepsin 
digestion suggesting that it is indeed a precursor of the ¢tl chain 
(lanes 2 and 4). The decrease in type X collagen after heparin treat- 
ment can be seen in both the pepsinized and nonpepsinized samples 
(7.5% SDS-PAGE gels, all lanes reduced with DTT). The bands 
above ¢tl in lanes 2 and 4 represent the cartilage specific collagen 
chains 1  ¢t and 2tt that preferentially accumulate in the chondrocyte 
culture cell layers rather than the media (16). 
Heparin treatment resulted in the apparent augmentation 
of synthesis of a low molecular weight protein seen in the 
cell layer compartment of the vascular smooth muscle cells 
(Fig. 3, lanes 1 and 2). This finding is in agreement with a 
recent report that heparin causes an induction of the synthe- 
sis of a low molecular weight, collagenase-sensitive compo- 
nent in smooth muscle cell cultures (14). This component is 
susceptible to digestion with bacterial collagenase (data not 
shown) and migrates somewhat faster than the rat type X col- 
lagen  standard  isolated  from costochondral growth plates 
(Fig. 3). Upon treatment with pepsin, the short chain collag- 
enous component from smooth muscle cell cultures (SCum) 
undergoes more extensive proteolysis than the type X colla- 
gen standard, as evidenced by the observation that the result- 
ing fragments from SCum are too small to be retained on the 
gel (Fig.  4).  Comparing standards of type X  collagen ob- 
tained  from organ  cultures  of both chick and  rat growth 
plates with material from cell layers of heparin-treated rat 
vascular smooth muscle cell cultures demonstrates that when 
SCvsm is analyzed on the same 7.5% gel it has a molecular 
weight  of 56K,  and  migrates  slightly  further than  either 
chick or rat type X (59K). Moreover, there is no component 
in smooth muscle that comigrates with the type X standards, 
indicating that type X collagen is not synthesized by the rat 
vascular smooth muscle cell cultures (Fig.  5). 
Rat Swarm Chondrosarcoma Cell Cultures 
A similar increase in pN ¢tl precursor chains of  type II colla- 
gen was seen in both the media and cell layer compartments 
of  these tumor cells when treated with heparin. However, the 
marked decrease in the ctl and ct2 bands observed in the cell 
layer compartment of the vascular smooth muscle cell cul- 
tures after heparin treatment is not seen with the chondrosar- 
coma cell cultures.  We found no evidence that these cells 
synthesize type X collagen or that short chain collagen could 
be induced by heparin treatment. 
Effects similar to the observations with heparin were ob- 
tained when chondrocytes were treated with chondroitin sul- 
fate at a concentration of 100 ~tg/ml; synthesis of type X de- 
creased and there was an accumulation ofpN t~l. No changes 
in cell morphology were seen as a result of heparin or chon- 
droitin sulfate treatment in any of the cell types studied. The 
inhibitory effect of heparin on type X collagen synthesis and 
its inductive effect on SCv~m were reversed when treatment 
with heparin was discontinued (data not shown). 
Discussion 
Our  study has  shown that  exogenous glycosaminoglycans 
have effects on both processing and distribution of collagen 
that vary depending on the cell types studied. Steps in post- 
translational modification of these molecules have been sug- 
gested as potentially important sites in the regulation of col- 
lagen processing (7, 20). We have also shown that exogenous 
glycosaminoglycans have an inhibitory effect on the synthe- 
sis of type X collagen. 
From the present study it appears that treatment with hepa- 
rin inhibits at least one of the collagen-processing proteases 
and our data suggest that it is most likely the protease in- 
volved in  the  removal of the  NH2-terminal propeptide of 
procollagen. Quantitative assays with bacterial collagenase 
showed that in cultures of  chick chondrocytes heparin caused 
a decrease in total collagen synthesis. This may be due to the 
accumulation of collagen precursors and a possible feedback 
inhibition of protein synthesis at the translational level (8). 
The decrease in total collagen synthesis may reflect a diminu- 
tion in more than one collagen type and is exemplified by the 
decrease in type X collagen synthesis in the chick calcifying 
chondrocytes. 
Comparison of the three different cell types indicates a 
third effect of heparin on collagen synthesis in vitro. In the 
rat vascular smooth muscle cell cultures heparin appears to 
be acting as an effector of collagen release from the cell layer 
into the media. Both precursor as well as fully processed al 
and ¢t2 chains are released into the media. This is the reverse 
of our observations with heparin on the chick chondrocyte 
cultures where  collagen accumulation is  in  the cell layer 
compartment. While the Swarm chondrosarcoma cell cul- 
tures showed a similar increase in the precursor region, no 
significant shift of either precursor or processed collagen 
molecules between cell layer and media was noted. This sug- 
gests that at the concentrations used, heparin does not appear 
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smooth  muscle  cells and  (b)  rat  Swarm  chon- 
drosarcoma cells. Accumulation  of  precursor to ttl 
(a~s  at ps level) can be seen in both cell types 
in cultures treated with heparin (lanes 4, 7, and 9). 
Heparin produces a release of both precursors and 
processed chains from the cell layer into the media 
particularly in the vascular smooth muscle cell 
cultures. This is in contrast to the effect of heparin 
on  cultures  of  either  calcifying  or  permanent 
chondrocytes from chick sternae. There is also a 
significant diminution in the ttl and ¢t2 chains in 
the cell layer compartment of the vascular smooth 
muscle cultures (arrow at ¢tl level, lane 2). As a 
result of heparin treatment there is a  relative in- 
crease of a low molecular weight component (ar- 
rowheads,  lanes 1  and 2) which migrates some- 
what  faster  than  the  type X  collagen standard 
isolated from growth plate (X, lane 5). This com- 
ponent  (SC,~),  described previously as a  short 
chain collagen because of its susceptibility  to bac- 
terial collagenase, is also sensitive to limited pep- 
sin digestion. The short chain collagen synthesized 
by rat smooth muscle cells is therefore not type X 
collagen (see Fig. 4). (7.5 % SDS-PAGE gels with 
all lanes reduced). 
to have as strong an effect on the alteration of collagen distri- 
bution in the chondrosarcoma cells as was seen in the other 
cell types studied. 
Rat vascular smooth muscle cells produce predominantly 
types I and HI collagen, while chick chondrocytes and Swarm 
Figure 4.  Pepsin digestion of heparin-treated rat vascular smooth 
muscle cell layers: comparison with type X collagen standard iso- 
lated from the chick tibiotarsus growth plate (GP). The low molec- 
ular  weight  bacterial  collagenase-sensitive component  that  in- 
creases in the presence of heparin (Fig. 3, SCum) disappears upon 
pepsin digestion. The nonpepsinized form (a~head,  lane 3) mi- 
grates at a level just below the nonpepsinized type X  standard in 
lane 1. No bands can be seen in lane 4 that could be identified as 
the products of pepsinized type X in lane 2 (7.5 % SDS-PAGE gels 
with all lanes reduced). 
Figure 5. Comparison of type X collagen isolated from chick tibio- 
tarsus  (lane  1)  and  rat costochondral junction  (lane 2)  growth 
plates, with the short chain collagenous component (SCum) of rat 
vascular smooth muscle cell cultures (lane 3). The short chain com- 
ponent seen in lane 3 (SCum) migrates faster than the chick and rat 
type X seen in lanes 1 and 2  and, there is no component in lane 
3 that comigrates with the type X standard. 
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which are less abundant.  These cells could each have differ- 
ent receptors for heparin,  thus explaining the difference in 
response.  Alternatively  the extracellular matrix of Swarm 
chondrosarcoma is relatively less well organized than in car- 
tilage or blood vessels, and the different effects of heparin on 
the distribution  of collagen between the media and cell layer 
compartments of the various cell types could be due to differ- 
ent interactions  with extracellular matrix molecules. 
While our findings  that SCvsm and type X are susceptible 
to collagenase and only type X is resistant  to pepsin are in 
conflict with a report  that SC,~m is resistant  to pepsin in a 
fashion similar to type X (15), our observations that type X 
and SCvsm (a) do not comigrate on gels, (b) are variably  sus- 
ceptible to proteolysis with pepsin, and (c) type X synthesis 
is  inhibited  whereas  SC,~m synthesis  is  augmented  when 
cells  are  treated  with heparin  strongly  suggest  that  SCvsm 
and  type  X  are  distinct  collagenous  proteins.  Moreover, 
different cellular responses to heparin indicate that the mech- 
anisms involved in the regulation of these two collagens are 
different. 
SCvsm is possibly  a new type of collagen synthesized by 
rat vascular  smooth muscle cells and induced by heparin, 
and may be a different gene product or a degradation  product 
of one of the major,  better characterized collagen types.  In 
cultures of chick permanent chondrocytes, heparin did not 
induce the synthesis of type X collagen and in fact inhibited 
type X synthesis in chick calcifying chondrocyte cultures. By 
contrast, vascular smooth muscle cells respond to heparin by 
increasing the synthesis of a short chain collagen that is not 
type X. Susceptibility of SCwm to both bacterial  collagenase 
and to pepsin may be explained by insufficient triple helicity 
and thereby  inability  to withstand partial  proteolysis  with 
pepsin. Its relatively similar molecular weight to type X col- 
lagen is consistent with the concept of a new family of short 
chain collagens.  A  "cassette" model has been proposed for 
at least one collagen (type VIII), envisioning tandem repeats 
of collagenous sequences comprised of 50,000-kD domains, 
alternating  with shorter,  noncollagenous domains (23). 
Patients  encountering  pulmonary  emboli  from  venous 
thrombosis are usually placed on intravenous  heparin  as an 
anticoagulant.  The inhibitory effect of heparin on collagen 
synthesis  in chondrocytes  emphasizes  the possible delete- 
rious  effects  on  healing  fractures  and  developing  growth 
plates, particularly  since we have shown an inhibitory  effect 
on type X collagen that is unique to endochondral ossifica- 
tion.  This effect on collagen synthesis  in vascular  smooth 
muscle cells may play a role in the intracranial hemorrhage 
seen in premature  infants  that are prophylactically  antico- 
agulated with heparin. There has also been at least one case 
report of heparin-induced osteoporosis as a result of long- 
term intravenous  heparin therapy  (22). 
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